Targeting NEU Protein in Melanoma Cells with Non-Thermal Atmospheric Pressure Plasma and Gold Nanoparticles
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- JOURNAL OF BIOMEDICAL NANOTECHNOLOGY11(5) · pp.900 · 2015
- 피인용
- Web of Science 27
- JCR IF
- JCR 2014 5.338
- ISSN
- 1550-7033
저자
초록
Non-thermal atmospheric pressure plasma effectively kills cancer cells, but it cannot selectively kill cancer cells. The authors targeted NEU (human epidermal growth factor receptor 2) protein, which is frequently over-expressed in the cell membrane of melanoma cells, using anti-NEU antibody-labeled gold nanoparticles. The labeled nanoparticles preferentially targeted melanoma cells rather than normal keratinocytes. After the addition of labeled gold nanoparticles to melanoma and normal keratinocyte cells, both cells were exposed to non-thermal atmospheric pressure plasma. The death rate of melanoma cells was significantly higher than that of normal keratinocyte cells; many vacuoles, indicative of cell death, were observed in melanoma cells treated with anti-NEU antibody labeled gold nanoparticles and plasma. This selective cancer cell death was attributed to the selective destruction of NEU protein and a downstream effector of NEU. Our study findings show that treatment with a combination of non-thermal atmospheric pressure plasma and anti-NEU antibody-labeled gold nanoparticles effectively and selectively kills melanoma cells.
키워드
Gold NanoparticlesNon-Thermal Atmospheric Pressure PlasmaMelanomaNEUSelective Cell DeathOVARIAN-CANCER CELLSFOCAL ADHESION KINASEHER2NANOTECHNOLOGYIMMUNOTHERAPYMOTILITYTHERAPYPTPN12FAK
식별자
- WoS UID
- 000344969800013



로그인
연구물 목록으로